(IN BRIEF) Scientists at the Institute of Cancer Research in London are contributing to an international clinical trial evaluating THEO-260, an experimental oncolytic immunotherapy designed to treat platinum-resistant ovarian cancer. The trial, known as OCTOPOD-IV, is being supported by €8 … Read the full press release →
Posted in Business, Education, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Alan Melcher, cancer associated fibroblasts CAF, Cancer Center Clínica Universidad de Navarra, cancer immunotherapy development, Catalan Institute of Oncology, Horizon Europe funding, ICR cancer research, Institute of Cancer Research Joins International Trial of Novel Oncolytic Immunotherapy for Platinum-Resistant Ovarian Cancer, Institute of Cancer Research London, International Cancer Research Collaboration Advances Clinical Study of THEO-260 Immunotherapy for Hard-to-Treat Ovarian Tumours, Margaret Duffy, OCTOPOD IV clinical trial, oncolytic virus therapy, ovarian cancer research, platinum resistant ovarian cancer, Princess Margaret Cancer Centre, THEO 260 oncolytic immunotherapy, Theolytics biotechnology, translational cancer research, tumour microenvironment research
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
